REG-BARCLAYS PLC FORM 8.3 - WILLIS TOWERS WATSON PLC - AMENDMENT
04/03/2021 13:40
For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20210304:nBw60S3qYa&default-theme=true
FORM 8.3 - WILLIS TOWERS WATSON PLC - AMENDMENT
FORM 8.3
Amendment to sales
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER
RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR
MORE
1. KEY INFORMATION
Name of person dealing (Note 1) Barclays PLC.
Company dealt in WILLIS TOWERS WATSON PLC
Class of relevant security to which the ORD
dealings being disclosed relate (Note 2)
Date of dealing 02 March 2021
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant
security dealt in (Note 3)
Class of relevant security: ORD
Long Short
Number (%) Number (%)
(1) Relevant securities
1,877,218 1.46% 383,944 0.30%
(2) Derivatives (other than options):
153,127 0.12% 69,804 0.05%
(3) Options and agreements to
purchase/sell: 6,100 0.00% 6,100 0.00%
(4) TOTAL:
2,036,445 1.58% 459,848 0.36%
(b) Interests and short positions in relevant securities of the company, other
than the class dealt in (Note 3)
Class of relevant security: Long Short
Number (%) Number (%)
(1) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale Number of relevant securities Price per unit
Purchase 2 227.1800 USD
Purchase 5 225.5100 USD
Purchase 10 226.7200 USD
Purchase 38 227.3200 USD
Purchase 70 225.9000 USD
Purchase 100 226.0950 USD
Purchase 100 226.3100 USD
Purchase 107 226.3456 USD
Purchase 109 226.1566 USD
Purchase 200 225.9140 USD
Purchase 200 227.2900 USD
Purchase 291 227.2590 USD
Purchase 300 226.8099 USD
Purchase 469 228.2935 USD
Purchase 597 227.9842 USD
Purchase 700 226.8371 USD
Purchase 717 228.0148 USD
Purchase 1,085 227.7066 USD
Purchase 1,151 227.1099 USD
Purchase 1,217 227.3129 USD
Purchase 1,622 227.4403 USD
Purchase 1,790 227.6563 USD
Purchase 2,021 227.5768 USD
Purchase 3,352 226.1913 USD
Purchase 5,497 227.1100 USD
Purchase 8,221 227.5494 USD
Purchase 12,465 227.4397 USD
Purchase 24,455 227.2374 USD
Purchase 26,898 227.2053 USD
Sale 5 225.5100 USD
Sale 43 225.9900 USD
Sale 45 227.6200 USD
Sale 47 225.8923 USD
Sale 50 226.9100 USD
Sale 53 228.2100 USD
Sale 78 226.4800 USD
Sale 100 225.8700 USD
Sale 100 225.8550 USD
Sale 100 228.7200 USD
Sale 100 225.5500 USD
Sale 100 228.3250 USD
Sale 100 227.2000 USD
Sale 220 225.3481 USD
Sale 234 228.0085 USD
Sale 270 226.1241 USD
Sale 284 228.2833 USD
Sale 340 227.4885 USD
Sale 397 227.6178 USD
Sale 546 227.2433 USD
Sale 575 227.3473 USD
Sale 614 226.6143 USD
Sale 755 227.4005 USD
Sale 757 227.0385 USD
Sale 882 226.5347 USD
Sale 1,117 227.1464 USD
Sale 1,151 227.1099 USD
Sale 1,294 227.5252 USD
Sale 1,315 227.6895 USD
Sale 1,376 227.3200 USD
Sale 1,627 227.8643 USD
Sale 1,679 227.4234 USD
Sale 2,487 227.1100 USD
Sale 2,537 227.1470 USD
Sale 4,863 226.7868 USD
Sale 5,937 227.5038 USD
Sale 6,285 226.9142 USD
Sale 6,908 227.5103 USD
Sale 7,540 227.3732 USD
Sale 9,711 227.3891 USD
Sale 30,854 227.2544 USD
(b) Derivatives transactions (other than options transactions)
Product name, Nature of transaction Number of relevant securities Price per unit
e.g. CFD (Note 6) (Note 7) (Note 5)
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, Writing, selling, purchasing, varying etc. Number of securities to which the option relates (Note 7) Exercise price Type, e.g. American, European etc. Expiry date Option money paid/received per unit (Note 5)
e.g. call option
(ii) Exercising
Product name, Number of securities Exercise price per unit (Note 5)
e.g. call option
(d) Other dealings (including transactions in respect of new securities) (Note
4)
Nature of transaction Details Price per unit
(Note 8) (if applicable) (Note 5)
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person
disclosing and any other person relating to the voting rights of any relevant
securities under any option referred to on this form or relating to the voting
rights or future acquisition or disposal of any relevant securities to which
any derivative referred to on this form is referenced. If none, this should be
stated.
None
Is a Supplemental Form 8 (Open Positions) attached? YES
Date of disclosure: 4 Mar 2021
Contact name: Large Holdings Regulatory Operations
Telephone number: 020 3134 7213
If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection
SUPPLEMENTAL FORM 8
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997,
TAKEOVER RULES, 2013
DETAILS OF OPEN POSITIONS
(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or
Form 8.3, as appropriate)
OPEN POSITIONS (Note 1)
Product name Written or Number of Exercise Type Expiry
purchased relevant securities price date
to which the option
or derivative
relates
Put Options Purchased -100 220.0000 American Jul 16, 2021
Call Options Purchased 100 240.0000 American Jul 16, 2021
Call Options Purchased 6,000 220.0000 American Jul 16, 2021
Put Options Purchased -6,000 200.0000 American Jul 16, 2021
Notes
1. Where there are open option positions or open derivative positions (except
for CFDs), full details should be given. Full details of any existing
agreements to purchase or to sell must also be given on this form.
2. For all prices and other monetary amounts, the currency must be stated.
For full details of disclosure requirements, see Rule 8 of the Rules. If in
doubt, consult the Panel.
View source version on businesswire.com:
https://www.businesswire.com/news/home/20210304005608/en/
(https://www.businesswire.com/news/home/20210304005608/en/)
BARCLAYS PLC
Copyright Business Wire 2021Recent news on Barclays
See all newsREG - Barclays PLC Spire Healthcare Grp - Form 8.3 SPIRE HEALTHCARE GROUP PLC
AnnouncementREG - Barclays PLC British Land Co PLC - Form 8.3 BRITISH LAND COMPANY PLC, THE
AnnouncementREG - Barclays PLC IQE PLC - Form 8.3 IQE PLC
AnnouncementREG - Barclays PLC Intnl Personal Fin - Form 8.3 INTERNATIONAL PERSONAL FINANCE PLC
AnnouncementREG - Barclays PLC JTC PLC - Form 8.3 JTC PLC
Announcement